We began covering the business of medical imaging 20 years ago with a biweekly newsletter called DI SCAN. Last fall we turned DI SCAN into a weekly downloadable PDF and launched a new service, SCAN Business Daily, available free to anyone with a browser.
We began covering the business of medical imaging 20 years ago with a biweekly newsletter called DI SCAN. Last fall we turned DI SCAN into a weekly downloadable PDF and launched a new service, SCAN Business Daily, available free to anyone with a browser.
The new SCAN is part of DI's effort to take the fullest possible advantage of the Internet for its readers. There's still the premium side of the reporting, the subscription side, and you'll see how to access that in the newsletter embedded on the right side of Diagnostic Imaging's home page. Subscribers download this compilation of news and market analyses as an online magazine.
But stay on the home page and look to the left for a daily rundown on the news itself. You'll find a summary of the day's happenings and more. DI SCAN is tapped into what's coming up, not just in press releases, but in the kind of give and take that leads to the behind-the-scenes look at imaging that appears in our subscription newsletter. The basic facts are presented to you for the price of a mouse click, free from the marketing spin and with facts checked.
Who knew Claimpower Medical Billing is in Glen Rock, NJ, not Harristown? You did, but only if you read SCAN Business Daily. Our competition-all of it-got the street address and city mixed up. And we define terms and provide the context, drawing from SCAN's two decades of experience. Do you know a "destructed" lesion from a "nondestructed" one? Again, you would if you read SCAN Business Daily.
In SCAN Business Daily, we get everything right, right down to the details. Because we know that in medical imaging, that's how it has to be.
Greg Freiherr is editor of DI Scan
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.